Thyssenkrupp Nucera's Fiscal Year 2024/2025: Navigating Challenges and Achieving Growth

In fiscal year 2024/2025, Thyssenkrupp Nucera reported stable sales of EUR 845 million, a slight decrease from the previous year. However, the company achieved a significant turnaround in EBIT, reporting EUR 2 million from a previous negative EBIT of EUR 14 million. The company faced a challenging market environment, marked by a decline in order intake to EUR 348 million from EUR 636 million, largely impacted by green hydrogen market conditions.

The chlor-alkali segment saw a 14% rise in sales, while the service business drove a 15% increase in order intake. In contrast, the green hydrogen segment experienced a decrease in sales and a reduction in order backlog due to project dynamics. The company's proactive cost management and technology enhancements underpin its strategy for long-term growth, with a focus on both chlor-alkali and green hydrogen technologies.